← Leaderboards
Michelle Christine Mendoza
Harvard Medical School
$4,983,802
Attributed
$6,016,111
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,016,111 · 6
By mechanism
R01$4,179,182 · 3
R25$786,978 · 1
K01$690,397 · 1
R21$359,554 · 1
Top collaborators
- Donald E Ayer2 shared
- Gita Suneja2 shared
- Jeffrey A. Weiss2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBasic SciencePreventMutationSignal TransductionMolecularCancer CellRegulationNeoplasm MetastasisPhosphotransferasesCellsMutantActinsInnovationCarcinomaPhosphorylationNeoplastic CellMorbidity - Disease RateCell MotilityTissuesMediatingPathway InteractionsProgramsBiosensor
Grant awards (23)
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$461,852
R01 · FY2025 · CA · contact PI
Mechanical Stress and Lung Tumor Progression$461,181
R01 · FY2025 · CA
Kinase Control of Synergistic Cell Migration Mechanics$308,000
R01 · FY2025 · GM · contact PI
Huntsman Cancer Institute PathMaker Programs for Cancer Research$247,064
R25 · FY2025 · CA
Mechanical Stress and Lung Tumor Progression$554,133
R01 · FY2024 · CA
Huntsman Cancer Institute PathMaker Programs for Cancer Research$539,914
R25 · FY2024 · CA
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$438,759
R01 · FY2024 · CA · contact PI
Kinase Control of Synergistic Cell Migration Mechanics$308,000
R01 · FY2024 · GM · contact PI
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$31,259
R01 · FY2024 · CA · contact PI
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$503,421
R01 · FY2023 · CA · contact PI
Kinase Control of Synergistic Cell Migration Mechanics$307,750
R01 · FY2023 · GM · contact PI
Kinase Control of Synergistic Cell Migration Mechanics$66,515
R01 · FY2023 · GM · contact PI
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$32,904
R01 · FY2023 · CA · contact PI
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling$398,408
R01 · FY2022 · CA · contact PI
Kinase Control of Synergistic Cell Migration Mechanics$307,000
R01 · FY2022 · GM · contact PI
Differential Regulation of Tumor Invasion by RSK Family Isoforms$160,868
R21 · FY2019 · CA · contact PI
Differential Regulation of Tumor Invasion by RSK Family Isoforms$198,686
R21 · FY2018 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$162,060
K01 · FY2016 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$162,060
K01 · FY2015 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$122,186
K01 · FY2014 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$115,833
K01 · FY2013 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$6,353
K01 · FY2013 · CA · contact PI
Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway$121,905
K01 · FY2012 · CA · contact PI